Lack of association between polymorphic microsatellites of the VMAT2 gene and Parkinson's disease in Japan

Journal of the Neurological Sciences

Volumn 232, Issue 1-2, 2005, Pages 91-94

  Kariya, Shingo ^a   Hirano, Makito ^a   Takahashi, Nobuyuki ^b   Furiya, Yoshiko ^a   Ueno, Satoshi ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

^b Minoh City Hospital   (Japan)

Author keywords

Dopamine; Hallucination; Microsatellite; Parkinson's disease; Polymorphism; VMAT2

Indexed keywords

VESICULAR MONOAMINE TRANSPORTER 2;

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE MARKER; PARKINSON DISEASE; PRIORITY JOURNAL; PROMOTER REGION;

EID: 17844402225     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2005.02.005     Document Type: Article

References (30)

1. C.D. Marsden Parkinson's disease Lancet 335 1990 948 952
2. E. Hirsch, A.M. Graybiel, and Y.A. Agid Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease Nature 334 1988 345 348
3. M.B. Spina, and G. Cohen Dopamine turnover and glutathione oxidation: implications for Parkinson disease Proc Natl Acad Sci U S A 86 1989 1398 1400
4. R.G. Johnson Jr. Accumulation of biological amines into chromaffin granules: a model for hormone and neurotransmitter transport Physiol Rev 68 1988 232 307
5. J.P. Henry, D. Botton, C. Sagne, M.F. Isambert, C. Desnos, and V. Blanchard Biochemistry and molecular biology of the vesicular monoamine transporter from chromaffin granules J Exp Biol 196 1994 251 262
6. A.Y. Sun, and Y.M. Chen Oxidative stress and neurodegenerative disorders J Biomed Sci 5 1998 401 414
7. P. Jenner, and C.W. Olanow Understanding cell death in Parkinson's disease Ann Neurol 44 1998 S72 S84
8. J.M. Brown, G.R Hanson, and A.E. Fleckenstein Regulation of the vesicular monoamine transporter-2: a novel mechanism for cocaine and other psychostimulants J Pharmacol Exp Ther 296 2001 762 767
9. G.D. Zeevalk, L.P. Bernard, and W.J. Nicklas Role of oxidative stress and the glutathione system in loss of dopamine neurons due to impairment of energy metabolism J Neurochem 70 1998 1421 1430
10. J.R. Landry, D.L. Mager, and B.T. Wilhelm Complex controls: the role of alternative promoters in mammalian genomes Trends Genet 19 2003 640 648
11. H.S. Lo, E.L. Hogan, and B.W. Soong 5′-flanking region polymorphism of the neuronal nitric oxide synthase gene with Parkinson's disease in Taiwan J Neurol Sci 194 2002 11 13
12. N. Takahashi, and G. Uhl Murine vesicular monoamine transporter 2: molecular cloning and genomic structure Brain Res Mol Brain Res 49 1997 7 14
13. G.R. Uhl, S. Li, N. Takahashi, K. Itokawa, Z. Lin, and M. Hazama The VMAT2 gene in mice and humans: amphetamine responses, locomotion, cardiac arrhythmias, aging, and vulnerability to dopaminergic toxins FASEB J 14 2000 2459 2465
14. D.J. Gelb, E. Oliver, and S. Gilman Diagnostic criteria for Parkinson disease Arch Neurol 56 1999 33 39
15. N. Blin, and D.W. Stafford A general method for isolation of high molecular weight DNA from eukaryotes Nucleic Acids Res 3 1976 2303 2308
16. J.W. Langston The etiology of Parkinson's disease with emphasis on the MPTP story Neurology 47 1996 S153 S160
17. D.G. Le Couteur, P.W. Leighton, S.J. McCann, and S. Pond Association of a polymorphism in the dopamine-transporter gene with Parkinson's disease Mov Disord 12 1997 760 763
18. P.W. Leighton, D.G. Le Couteur, C.C. Pang, S.J. McCann, D. Chan, and L.K. Law The dopamine transporter gene and Parkinson's disease in a Chinese population Neurology 49 1997 1577 1579
19. H.H. Van Tol, C.M. Wu, H.C. Guan, K. Ohara, J.R. Bunzow, and O. Civelli Multiple dopamine D4 receptor variants in the human population Nature 358 1992 149 152
20. D.C. Wan, L.K. Law, D.T. Ip, W.T. Cheung, W.K. Ho, and K.W. Tsim Lack of allelic association of dopamine D4 receptor gene polymorphisms with Parkinson's disease in a Chinese population Mov Disord 14 1999 225 229
21. G.D. Mellick, D.D. Buchanan, S.J. McCann, K.M. James, A.G. Johnson, and D.R. Davis Variations in the monoamine oxidase B (MAOB) gene are associated with Parkinson's disease Mov Disord 14 1999 219 224
22. G.D. Mellick, D.D. Buchanan, P.A. Silburn, D.K. Chan, D.G. Le Couteur, and L.K. Law The monoamine oxidase B gene GT repeat polymorphism and Parkinson's disease in a Chinese population J Neurol 247 2000 52 55
23. G. Fenelon, F. Mahieux, R. Huon, and M. Ziegler Hallucinations in Parkinson's disease: prevalence, phenomenology and risk factors Brain 123 2000 733 745
24. C.G. Goetz, C. Vogel, C.M. Tanner, and G.T. Stebbins Early dopaminergic drug-induced hallucinations in parkinsonian patients Neurology 51 1998 811 814
25. J. Wang, C. Zhao, B. Chen, and Z.L. Liu Polymorphisms of dopamine receptor and transporter genes and hallucinations in Parkinson's disease Neurosci Lett 355 2004 193 196
26. N. Chen, and M.E. Reith Structure and function of the dopamine transporter Eur J Pharmacol 405 2000 329 339
27. M. Maes, and H.Y. Meltzer The serotonin hypothesis of major depression Psychopharmacology the 4th Generation of Progress 1995 Raven Press New York 933 944
28. P. Seeman, C. Ulpian, C. Bergeron, P. Riederer, K. Jellinger, and E. Gabriel Bimodal distribution of dopamine receptor densities in brains of schizophrenics Science 225 1984 728 731
29. G.F. Koob, and M. Le Moal Drug abuse and alcoholism. Overview Science 278 1997 52 58
30. E.J. Nestler, and G.K. Aghajanian Molecular and cellular basis of addiction Science 278 1997 58 63